Shuangping P. Zhang

Taiyuan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Neoadjuvant Chemoimmunotherapy versus Neoadjuvant Chemoradiotherapy versus Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Real-World, Three-Arm, Retrospective Cohort Study from the Chinese National Cancer Center.

Neoadjuvant Chemoimmunotherapy versus Neoadjuvant Chemoradiotherapy versus Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma: A Real-World, Three-Arm, Retrospective Cohort Study from the Chinese National Cancer Center.

Journal: Technology in cancer research & treatment

Published: June 08, 2026

Reshaping immunotherapy sequencing strategy: equivalent survival with induction plus consolidation vs. consolidation-only strategy in unresectable stage III NSCLC.

Reshaping immunotherapy sequencing strategy: equivalent survival with induction plus consolidation vs. consolidation-only strategy in unresectable stage III NSCLC.

Journal: Oncoimmunology

Published: May 16, 2026

Compact Differential Photoacoustic Exhaled Gas Sensor for Online ETCO2 and ETO2 Monitoring.

Compact Differential Photoacoustic Exhaled Gas Sensor for Online ETCO2 and ETO2 Monitoring.

Journal: ACS sensors

Published: January 27, 2026

Exploration of a new clinical classification of esophagogastric junction adenocarcinoma

Exploration of a new clinical classification of esophagogastric junction adenocarcinoma

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]

Published: January 26, 2026

Clinical efficacy and safety of an overall strategy of immunotherapy combined with chemoradiotherapy for limited-stage small cell lung cancer (including induction ± consolidation ± second-line immunotherapy): A propensity score matching study based on real-world data.

Clinical efficacy and safety of an overall strategy of immunotherapy combined with chemoradiotherapy for limited-stage small cell lung cancer (including induction ± consolidation ± second-line immunotherapy): A propensity score matching study based on real-world data.

Journal: Cancer treatment and research communications

Published: November 10, 2025

Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer.

Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer.

Journal: Frontiers in immunology

Published: October 28, 2025

Microbiota-mediated modulation of radiosensitivity: mechanisms and therapeutic prospects of oral and gut microbiota, metabolites, and probiotics.

Microbiota-mediated modulation of radiosensitivity: mechanisms and therapeutic prospects of oral and gut microbiota, metabolites, and probiotics.

Journal: Frontiers in microbiology

Published: August 21, 2025

Establishment of a new lymph node staging system and its efficacy in predicting postoperative prognosis of limited-stage small cell lung cancer

Establishment of a new lymph node staging system and its efficacy in predicting postoperative prognosis of limited-stage small cell lung cancer

Journal: Zhonghua yi xue za zhi

Published: May 15, 2025

CT Radiomic Nomogram Using Optimal Volume of Interest for Preoperatively Predicting Invasive Mucinous Adenocarcinomas in Patients with Incidental Pulmonary Nodules: A Multicenter, Large-Scale Study.

CT Radiomic Nomogram Using Optimal Volume of Interest for Preoperatively Predicting Invasive Mucinous Adenocarcinomas in Patients with Incidental Pulmonary Nodules: A Multicenter, Large-Scale Study.

Journal: Technology in cancer research & treatment

Published: December 20, 2024

Shifting landscapes of gender equity in oncology journals: a decade of authorship trends.

Shifting landscapes of gender equity in oncology journals: a decade of authorship trends.

Journal: Molecular cancer

Published: December 03, 2024

Prognostic Implications of Programmed Cell Death Ligand 1 Expression, Cluster of Differentiation 8-Positive T-Cell Infiltration, and Related Immunophenotypes in Invasive Mucinous Adenocarcinoma of the Lung: A Multicenter Study.

Prognostic Implications of Programmed Cell Death Ligand 1 Expression, Cluster of Differentiation 8-Positive T-Cell Infiltration, and Related Immunophenotypes in Invasive Mucinous Adenocarcinoma of the Lung: A Multicenter Study.

Journal: MedComm

Published: November 19, 2024

Exploring the Clinical Value of Perioperative ctDNA-Based Detection of Molecular Residual Disease in Patients With Esophageal Squamous Cell Carcinoma.

Exploring the Clinical Value of Perioperative ctDNA-Based Detection of Molecular Residual Disease in Patients With Esophageal Squamous Cell Carcinoma.

Journal: Thoracic cancer

Published: November 12, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026